Correlation Between Spyre Therapeutics and Evofem Biosciences
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Evofem Biosciences, you can compare the effects of market volatilities on Spyre Therapeutics and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Evofem Biosciences.
Diversification Opportunities for Spyre Therapeutics and Evofem Biosciences
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spyre and Evofem is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Evofem Biosciences go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Evofem Biosciences
If you would invest 2,660 in Spyre Therapeutics on September 3, 2024 and sell it today you would earn a total of 183.00 from holding Spyre Therapeutics or generate 6.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 0.0% |
Values | Daily Returns |
Spyre Therapeutics vs. Evofem Biosciences
Performance |
Timeline |
Spyre Therapeutics |
Evofem Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Spyre Therapeutics and Evofem Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and Evofem Biosciences
The main advantage of trading using opposite Spyre Therapeutics and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.Spyre Therapeutics vs. Milestone Pharmaceuticals | Spyre Therapeutics vs. Seres Therapeutics | Spyre Therapeutics vs. DiaMedica Therapeutics | Spyre Therapeutics vs. Lyra Therapeutics |
Evofem Biosciences vs. Sabra Healthcare REIT | Evofem Biosciences vs. ChampionX | Evofem Biosciences vs. Dream Finders Homes | Evofem Biosciences vs. Parker Hannifin |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |